139 related articles for article (PubMed ID: 11966862)
1. Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.
Mathew NT
Headache; 2002 Jan; 42 Suppl 1():32-7. PubMed ID: 11966862
[TBL] [Abstract][Full Text] [Related]
2. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
Cady R
Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861
[TBL] [Abstract][Full Text] [Related]
3. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
4. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
Dodick DW
Headache; 2002 Jan; 42(1):21-7. PubMed ID: 12005271
[TBL] [Abstract][Full Text] [Related]
5. Early intervention with almotriptan improves sustained pain-free response in acute migraine.
Mathew NT
Headache; 2003; 43(10):1075-9. PubMed ID: 14629242
[TBL] [Abstract][Full Text] [Related]
6. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
7. A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
Mathew NT;
Headache; 2002 Jan; 42(1):32-40. PubMed ID: 12005273
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
Cabarrocas X;
Clin Ther; 2001 Nov; 23(11):1867-75. PubMed ID: 11768838
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Linder SL; Mathew NT; Cady RK; Finlayson G; Ishkanian G; Lewis DW
Headache; 2008 Oct; 48(9):1326-36. PubMed ID: 18484981
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
13. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better.
Pascual J; Cabarrocas X
Headache; 2002 Jan; 42(1):28-31. PubMed ID: 12005272
[TBL] [Abstract][Full Text] [Related]
14. Almotriptan: a review of its use in migraine.
Keam SJ; Goa KL; Figgitt DP
Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Allais G; Bussone G; D'Andrea G; Moschiano F; d'Onofrio F; Valguarnera F; Manzoni GC; Grazzi L; Allais R; Benedetto C; Acuto G
Cephalalgia; 2011 Jan; 31(2):144-51. PubMed ID: 20660540
[TBL] [Abstract][Full Text] [Related]
17. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
18. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
[TBL] [Abstract][Full Text] [Related]
19. Eletriptan for acute migraine.
Smith LA; Oldman AD; McQuay HJ; Moore RA
Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
[TBL] [Abstract][Full Text] [Related]
20. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
Mondell BE
Clin Ther; 2003 Feb; 25(2):331-41. PubMed ID: 12749502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
